Adam J. Bass
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adam J. Bass has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Charles S. Fuchs
Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts
1 shared publicationEdward L. Giovannucci
1 shared publicationJeffrey A. Meyerhardt
Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts
1 shared publicationJennifer A. Chan
Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts
1 shared publication
Latest Publications
- Open Access
Family history and survival after colorectal cancer diagnosis
BACKGROUND: A history of colorectal cancer in a first‐degree relative is a recognized risk factor for developing this malignancy. The influence of a family history of colorectal cancer on survival after a diagnosis of colorectal cancer was examined in a large cohort of women.METHODS: We analyzed data from 1001 women diagnosed with colorectal cancer while participating in a prospective cohort study. Data on family history were obtained before cancer diagnosis. We computed Cox proportional hazards for cancer‐specific and overall mortality according to a family history of colorectal cancer, adjusting for other predictors for survival.RESULTS: Before diagnosis, 16% of colorectal patients reported a history of colorectal cancer in a first‐degree relative. Patients with a history of colorectal cancer in 1 or more first‐degree relatives experienced an adjusted hazard ratio (HR) for overall mortality of 1.32 (95% confidence interval [CI], 1.01–1.72) and colorectal cancer‐specific mortality of 1.38 (95% CI, 1.02–1.86) when compared with those without a family history. Moreover, patients with 2 or more affected relatives had an HR for overall mortality of 2.07 (95% CI, 1.14–3.76) and cancer‐specific mortality of 2.19 (95% CI, 1.10–4.38). The significant deleterious effect of family history was limited to patients with advanced disease at presentation and cancers originating in the colon.CONCLUSIONS: Among women with colorectal cancer, a history of colorectal cancer in a first‐degree relative was associated with a significant decrease in survival. Additional study is needed to validate these findings and determine whether specific germline polymorphisms correlate with clinical outcomes. Cancer 2008. © 2008 American Cancer Society.
Open AccessFamily history and survival after colorectal cancer diagnosis
BACKGROUND: A history of colorectal cancer in a first‐degree relative is a recognized risk factor for developing this malignancy. The influence of a family history of colorectal cancer on survival after a diagnosis of colorectal cancer was examined in a large cohort of women.METHODS: We analyzed data from 1001 women diagnosed with colorectal cancer while participating in a prospective cohort study. Data on family history were obtained before cancer diagnosis. We computed Cox proportional hazards for cancer‐specific and overall mortality according to a family history of colorectal cancer, adjusting for other predictors for survival.RESULTS: Before diagnosis, 16% of colorectal patients reported a history of colorectal cancer in a first‐degree relative. Patients with a history of colorectal cancer in 1 or more first‐degree relatives experienced an adjusted hazard ratio (HR) for overall mortality of 1.32 (95% confidence interval [CI], 1.01–1.72) and colorectal cancer‐specific mortality of 1.38 (95% CI, 1.02–1.86) when compared with those without a family history. Moreover, patients with 2 or more affected relatives had an HR for overall mortality of 2.07 (95% CI, 1.14–3.76) and cancer‐specific mortality of 2.19 (95% CI, 1.10–4.38). The significant deleterious effect of family history was limited to patients with advanced disease at presentation and cancers originating in the colon.CONCLUSIONS: Among women with colorectal cancer, a history of colorectal cancer in a first‐degree relative was associated with a significant decrease in survival. Additional study is needed to validate these findings and determine whether specific germline polymorphisms correlate with clinical outcomes. Cancer 2008. © 2008 American Cancer Society.